MedPath

The Role of POLE Mutation in High Risk Endometrial Cancer.

Recruiting
Conditions
Endometrial Neoplasms
Registration Number
NCT07114653
Lead Sponsor
Far Eastern Memorial Hospital
Brief Summary

The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is:

What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?

Detailed Description

All high-risk recurrent endometrial cancer cases who were treated in a tertiary referral center will be analyzed and subjected to POLE mutation analysis. In addition, survival analysis will be used to analyze the role of POLE mutations in women with high-risk endometrial cancer. We can answers the following.

1. What is the prevalence of POLE mutations in women with high-risk endometrial cancer?

2. What is the role of POLE mutations in real world high-risk endometrial cancer?

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • women with high-risk for recurrent endometrial cancer
Exclusion Criteria
  • Nil

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of POLE mutation in high risk endometrial cancer2 years

The prevalence of POLE mutations in women with high-risk for recurrent endometrial cancer

Secondary Outcome Measures
NameTimeMethod
The impact of POLE on overall survival5 years

The impact of POLE on overall survival, compared with the other TCGA groups

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital

🇨🇳

Banqiao, New Taipei, Taiwan

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
🇨🇳Banqiao, New Taipei, Taiwan
Sheng-Mou Hsiao, MD
Contact
+886-2-89667000
smhsiao2@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.